Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma

Multiple myeloma (MM) patients eventually develop multi-drug-resistant disease with poor survival. Hence, the development of novel treatment strategies is of great importance. Recently, different classes of immunotherapeutic agents have shown great promise in heavily pre-treated MM, including T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosny, Mashhour, Verkleij, Christie P. M., van der Schans, Jort, Frerichs, Kristine A., Mutis, Tuna, Zweegman, Sonja, van de Donk, Niels W. C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509238/
https://www.ncbi.nlm.nih.gov/pubmed/34640611
http://dx.doi.org/10.3390/jcm10194593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509238/
https://www.ncbi.nlm.nih.gov/pubmed/34640611
http://dx.doi.org/10.3390/jcm10194593

Ejemplares similares